<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Optimize Target Identification and MOA Studies

Correctly identifying drug targets and elucidating MOA is a critical stage in early drug development. Disease-relevant cell-based platforms are needed, which can quickly and easily transition to linked later stage ex vivo and in vivo models, for efficient go/no go preclinical program decisions.